Labiana Health, S.A. (BME:LAB)
4.780
0.00 (0.00%)
Last updated: Dec 4, 2025, 12:07 PM CET
Labiana Health Revenue
Labiana Health had revenue of 39.93M EUR in the half year ending June 30, 2025, with 36.80% growth. This brings the company's revenue in the last twelve months to 71.67M, up 8.37% year-over-year. In the year 2024, Labiana Health had annual revenue of 67.37M with 12.86% growth.
Revenue (ttm)
71.67M
Revenue Growth
+8.37%
P/S Ratio
0.47
Revenue / Employee
181.91K
Employees
369
Market Cap
33.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 67.37M | 7.68M | 12.86% |
| Dec 31, 2023 | 59.70M | -1.06M | -1.74% |
| Dec 31, 2022 | 60.76M | 1.31M | 2.21% |
| Dec 31, 2021 | 59.44M | -658.32K | -1.10% |
| Dec 31, 2020 | 60.10M | 9.40M | 18.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.09B |
| Laboratorios Farmaceuticos Rovi | 724.20M |
| Faes Farma | 571.12M |
| Laboratorio Reig Jofre | 330.34M |
| Clínica Baviera | 296.76M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |